A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy.
- Published In:
- Diabetes research and clinical practice, 217, 111871 (2024)
- Authors:
- Cheng, Alice Y Y, Mauricio, Didac, Ritzel, Robert, Al-Sofiani, Mohammed E, Bailey, Timothy, Aileen Mabunay, Maria, Bonnemaire, Mireille, Melas-Melt, Lydie, Mimouni, Safia, Davies, Melanie
- Database ID:
- RPEP-07988
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07988APA
Cheng, Alice Y Y; Mauricio, Didac; Ritzel, Robert; Al-Sofiani, Mohammed E; Bailey, Timothy; Aileen Mabunay, Maria; Bonnemaire, Mireille; Melas-Melt, Lydie; Mimouni, Safia; Davies, Melanie. (2024). A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy.. Diabetes research and clinical practice, 217, 111871. https://doi.org/10.1016/j.diabres.2024.111871
MLA
Cheng, Alice Y Y, et al. "A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy.." Diabetes research and clinical practice, 2024. https://doi.org/10.1016/j.diabres.2024.111871
RethinkPeptides
RethinkPeptides Research Database. "A post-hoc pooled analysis to evaluate efficacy and safety o..." RPEP-07988. Retrieved from https://rethinkpeptides.com/research/cheng-2024-a-posthoc-pooled-analysis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.